Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Original Research

Published on 02 May 2023

Comparison of clinicopathological characteristics and long-term survival between patients with gallbladder adenosquamous carcinoma and pure gallbladder adenocarcinoma after curative-intent surgery: a single-center experience in China and a meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tian-Run Lv
Fei Liu
Zuo-Yu Liang
Rui-Qi Zou
Wen-Jie Ma
Hai-Jie Hu
Fu-Yu Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1116275

1,624 views
4 citations

Original Research

Published on 02 May 2023

Comparison of NK cell subsets, receptors and functions induced by radiofrequency ablation and microwave ablation in HBV-associated primary hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hai-Yan Wang
Xiong-Wei Cui
Yong-Hong Zhang
Yu Chen
Ning-Ning Lu
Shou-Peng Sheng
Wen-Feng Gao
Xiao-Zheng Yang
Zhong-Ping Duan

Frontiers in Oncology

doi 10.3389/fonc.2023.1048049

2,286 views
1 citation

Case Report

Published on 02 May 2023

Case Report: Pancreatic and hepatic kaposiform hemangioendothelioma presenting as consumptive coagulopathy and right hepatic atrophy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Chengbo Ai
Tong Qiu
Jiangyuan Zhou
Chuan Wang
Jiulin Song
Siyu Pu
Shuguang Jin

Frontiers in Oncology

doi 10.3389/fonc.2023.1097997

1,877 views

Original Research

Published on 01 May 2023

Camrelizumab plus gemcitabine and oxaliplatin for the treatment of advanced intrahepatic cholangiocarcinoma: a bi-centric observational retrospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yu-Qing Zhang
Kang Wang
Jin-Kai Feng
Lu-Yun Yuan
Chao Liang
Yan-Jun Xiang
Xu Wang
Fei-Fei Mao
Shu-Qun Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1101038

2,528 views
5 citations

Review

Published on 01 May 2023

An overview of extrahepatic cholangiocarcinoma: from here to where?

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yongheng Yang
Xiaolu Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1171098

6,236 views
14 citations

Review

Published on 28 Apr 2023

Recent advances of three-dimensional bioprinting technology in hepato-pancreato-biliary cancer models

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xiaomei Zhuang
Gang Deng
Xiaoying Wu
Juping Xie
Dong Li
Songlin Peng
Di Tang
Guoying Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1143600

7,933 views
11 citations

Original Research

Published on 27 Apr 2023

An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yang Chen
Qiao-xin Lin
Yi-ting Xu
Fang-jing Qian
Chen-jing Lin
Wen-ya Zhao
Jing-ren Huang
Ling Tian
Dian-na Gu

Frontiers in Oncology

doi 10.3389/fonc.2023.1158605

6,010 views
13 citations

Review

Published on 26 Apr 2023

Recent advances in oncolytic virus therapy for hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Licheng Zhu
Yu Lei
Jia Huang
Yahang An
Yanqiao Ren
Lei Chen
Huangxuan Zhao
Chuansheng Zheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1172292

7,397 views
18 citations

Original Research

Published on 25 Apr 2023

The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Fuming Xie
Yao Zheng
Wen Fu
Bojing Chi
Xianxing Wang
Junfeng Zhang
Jianyou Gu
Jingyang Yin
Qiang Zhou
Shixiang Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1138238

4,342 views
10 citations

Original Research

Published on 24 Apr 2023

Terminal fucosylation of haptoglobin in cancer-derived exosomes during cholangiocarcinoma progression

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hyewon Choi
Sungeun Ju
Keunsoo Kang
Moon-Hyeong Seo
Jin-Man Kim
Eiji Miyoshi
Min-Kyung Yeo
Seung-Yeol Park

Frontiers in Oncology

doi 10.3389/fonc.2023.1183442

4,470 views
11 citations

Original Research

Published on 20 Apr 2023

A new model based on gamma-glutamyl transpeptidase to lymphocyte ratio and systemic immune-inflammation index can effectively predict the recurrence of hepatocellular carcinoma after liver transplantation

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Weiqi Zhang
Yi Bi
Kai Yang
Yan Xie
Zhaoxian Li
Xinghui Yu
Li Zhang
Wentao Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1178123

1,930 views
3 citations

Correction

Published on 19 Apr 2023

Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ping Chen
Haolin Song
Wei Xu
Jin Guo
Jianfei Wang
Juhong Zhou
Xiang Kang
Chaolei Jin
Yubo Cai
Zixuan Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1170066

1,572 views

Original Research

Published on 18 Apr 2023

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yixian He
Yunyang Wu
Mengqi Song
Yanlong Yang
Yizhi Yu
Sheng Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1149370

4,098 views
6 citations

Review

Published on 17 Apr 2023

Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Bin Guo
Qian Chen
Zhicheng Liu
Xiaoping Chen
Peng Zhu

Frontiers in Oncology

doi 10.3389/fonc.2023.1098958

6,460 views
11 citations

Methods

Published on 17 Apr 2023

TIDE: adjuvant tislelizumab plus donafenib combined with transarterial chemoembolization for high-risk hepatocellular carcinoma after surgery: protocol for a prospective, single-arm, phase II trial

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Weili Qi
Wei Peng
Xin Qi
Zhancheng Qiu
Tianfu Wen
Chuan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1138570

3,502 views
9 citations

Case Report

Published on 17 Apr 2023

RET rearrangement-positive pancreatic cancer has remarkable response to pralsetinib: a case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tongyi Zhang
Hongwei Wang
Zhiwei Cai
Siqi Zhang
Chongyi Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1078076

4,489 views
8 citations